- Home
- TCBI vs HAE Comparison
TCBI vs HAE Comparison
Compare TCBI & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBI
- HAE
- Stock Information
- Founded
- TCBI 1996
- HAE 1971
- Country
- TCBI United States
- HAE United States
- Employees
- TCBI N/A
- HAE N/A
- Industry
- TCBI Major Banks
- HAE Medical/Dental Instruments
- Sector
- TCBI Finance
- HAE Health Care
- Exchange
- TCBI Nasdaq
- HAE Nasdaq
- Market Cap
- TCBI 3.9B
- HAE 3.3B
- IPO Year
- TCBI N/A
- HAE 1991
- Fundamental
- Price
- TCBI $86.98
- HAE $52.21
- Analyst Decision
- TCBI Hold
- HAE Buy
- Analyst Count
- TCBI 13
- HAE 10
- Target Price
- TCBI $82.77
- HAE $84.20
- AVG Volume (30 Days)
- TCBI 426.4K
- HAE 908.6K
- Earning Date
- TCBI 10-16-2025
- HAE 11-06-2025
- Dividend Yield
- TCBI N/A
- HAE N/A
- EPS Growth
- TCBI N/A
- HAE 46.89
- EPS
- TCBI 2.50
- HAE 3.28
- Revenue
- TCBI $936,954,000.00
- HAE $1,346,046,000.00
- Revenue This Year
- TCBI $47.34
- HAE N/A
- Revenue Next Year
- TCBI $9.49
- HAE $6.50
- P/E Ratio
- TCBI $34.88
- HAE $15.90
- Revenue Growth
- TCBI N/A
- HAE 0.91
- 52 Week Low
- TCBI $59.37
- HAE $50.68
- 52 Week High
- TCBI $94.61
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- TCBI 56.55
- HAE 30.00
- Support Level
- TCBI $86.20
- HAE $53.10
- Resistance Level
- TCBI $88.30
- HAE $54.52
- Average True Range (ATR)
- TCBI 1.56
- HAE 1.22
- MACD
- TCBI 0.02
- HAE 0.53
- Stochastic Oscillator
- TCBI 60.60
- HAE 7.61
About TCBI Texas Capital Bancshares Inc.
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.